Functional Role of the microRNA-200 Family in Breast Morphogenesis and Neoplasia.

Functional Role of the microRNA-200 Family in Breast Morphogenesis and Neoplasia.
复制标题

DOI:
10.3390/genes5030804
复制
发表时间:
2014-09-11
期刊:
影响因子:
3.5
通讯作者:
Gudjonsson T
Gudjonsson T
中科院分区:
生物学3区
文献类型:
--
作者:
Hilmarsdottir B;Briem E;Bergthorsson JT;Magnusson MK;Gudjonsson T

文献摘要

参考文献

被引文献

相似文献

分支上皮形态发生与上皮-间质转化(EMT)密切相关,EMT是正常发育和癌症进展中的重要过程。miR-200家族通过与ZEB 1和ZEB 2转录因子的负反馈环调节上皮形态发生和EMT。miR-200抑制ZEB 1/2 mRNA的表达,这反过来可以下调miR-200家族,进一步导致E-钙粘蛋白的下调和间充质表型的诱导。最近的研究表明,miR-200基因在妊娠晚期和哺乳期高表达,从而表明这些miR对乳腺上皮的形态发生和分化很重要。miR-200基因已被深入研究与乳腺癌进展和转移的关系,其中已显示miR-200成员在EMT表型突出的基底样乳腺癌中下调。越来越多的证据表明miR-200家族在远端乳腺转移中上调,表明这些miR通过诱导间充质向上皮转化对转移性乳腺癌细胞的定殖很重要。miR-200在原发性和转移性乳腺癌中的双重作用对未来的治疗干预很有意义,因此更详细地了解其作用和相互作用的伙伴非常重要。
Branching epithelial morphogenesis is closely linked to epithelial-to-mesenchymal transition (EMT), a process important in normal development and cancer progression. The miR-200 family regulates epithelial morphogenesis and EMT through a negative feedback loop with the ZEB1 and ZEB2 transcription factors. miR-200 inhibits expression of ZEB1/2 mRNA, which in turn can down-regulate the miR-200 family that further results in down-regulation of E-cadherin and induction of a mesenchymal phenotype. Recent studies show that the expression of miR-200 genes is high during late pregnancy and lactation, thereby indicating that these miRs are important for breast epithelial morphogenesis and differentiation. miR-200 genes have been studied intensively in relation to breast cancer progression and metastasis, where it has been shown that miR-200 members are down-regulated in basal-like breast cancer where the EMT phenotype is prominent. There is growing evidence that the miR-200 family is up-regulated in distal breast metastasis indicating that these miRs are important for colonization of metastatic breast cancer cells through induction of mesenchymal to epithelial transition. The dual role of miR-200 in primary and metastatic breast cancer is of interest for future therapeutic interventions, making it important to understand its role and interacting partners in more detail.
DOI: 10.1038/srep03151
发表时间: 2013-11-06
期刊: Scientific reports
影响因子: 4.6
作者:
Banyard J;Chung I;Wilson AM;Vetter G;Le Béchec A;Bielenberg DR;Zetter BR
通讯作者: Zetter BR
DOI: 10.1152/physiolgenomics.00091.2012
发表时间: 2013-02-01
影响因子: 4.6
作者:
Galio, Laurent;Droineau, Stephanie;Devinoy, Eve
通讯作者: Devinoy, Eve
DOI: 10.1158/0008-5472.can-08-1942
发表时间: 2008-10-01
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Bracken, Cameron P.;Gregory, Philip A.;Goodall, Gregory J.
通讯作者: Goodall, Gregory J.
DOI: 10.1101/gr.111385.110
发表时间: 2011-05-01
期刊: GENOME RESEARCH
影响因子: 7
作者:
Arnold, Christopher P.;Tan, Ruoying;Chen, Chang-Zheng
通讯作者: Chen, Chang-Zheng
DOI: 10.1002/pros.22634
发表时间: 2013-06-01
期刊: PROSTATE
影响因子: 2.8
作者:
Bergthorsson, Jon Thor;Magnusson, Magnus Karl;Gudjonsson, Thorarinn
通讯作者: Gudjonsson, Thorarinn